Gou, M., Qu, T., Wang, Z., Yan, H., Si, Y., Zhang, Y., & Dai, G. (2021). Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer. Journal of Immunology Research, 1. https://doi.org/10.1155/2021/2549295
Chicago Style (17th ed.) CitationGou, Miaomiao, Tongtong Qu, Zhikuan Wang, Huan Yan, Yanhai Si, Yong Zhang, and Guanghai Dai. "Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer." Journal of Immunology Research 2021: 1. https://doi.org/10.1155/2021/2549295.
MLA (9th ed.) CitationGou, Miaomiao, et al. "Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer." Journal of Immunology Research, 2021, p. 1, https://doi.org/10.1155/2021/2549295.